πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6613740

Activity dependent neurotrophic factor III (ADNF III)

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6610295

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines,

Cogent Partners, LP Β· Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6605619

Nitroxides as protectors against oxidatives stress

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6602687

DNA encoding human ciliary neurotrophic factor and method for producing the protein encode

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6599744

Viral expression vectors comprising a ribosomal promoter sequence

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6593456

Tumor necrosis factor receptor releasing enzyme

The Regents of the University of California Β· Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6586573

Albumin-free Factor VIII formulations

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6576463

Hybrid vectors for gene therapy

The Regents of the University of California Β· Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566098

DNA encoding truncated hepatocyte growth factor variants

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566093

Alphavirus cDNA vectors

Bioption AB Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555367

Complex of biotinylated viral vector and ligand for targeted gene delivery

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551585

Use of tumor necrosis factor as an adjuvant

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6515118

DNA fragmentation factor

The Board of Regents of the University of Texas System Β· Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6503498

Apolipoprotein A-1 adenovirus vector compositions and methods

The Board of Regents of the University of Texas System Β· Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6500640

Nucleic acid molecules encoding modified dorsal tissue affecting factor

The Regents of the University of California Β· Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6475741

Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6472178

Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6468524

AAV4 vector and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451596

Helper adenovirus vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451763

Retinal pigmented epithelium derived neurotrophic factor and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6448072

Transcription factors related to TFIIA

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6440702

Nucleic acids encoding modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6420531

Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

The United States as represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410510

Administration modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired